On February 2, ZM pharmaceutical announced an exclusive worldwide license agreement with GSK for its proprietary TLR8 agonist CB06. Under the agreement......
The Chinese negotiation of the 2022 national medical insurance drug catalog officially ended on January 8.
According to the person in charge of the Department of Health Insurance Administration ......
Link Consulting is preparing the 《2022 BD strategy white book》 (Chinese Version). If you are interested in the license deals and BD strategy, please scan the QR code in the picture and leave your email.
Merck (NYSE: MRK), and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd), a clinical-stage biotech company focused on biologic and small molecule discovery and development ......
Thanks to the China's relaxing covid-19 policy, the annual meeting of the NDFC (New Drug Founders Club) was successfully held in Shanghai. 170 participants (83 Biotech founders) joined the event ......
Last Friday, A Charity event for Autism was organized. The event was sponsored by Guangdong Thank You Charity Foundation and the New Drug Founders Club (NDFC) together, named “New Drug Star Alliance, Light Up the Starry Sky".
Even the core assets are being sold, the difficulties of "Fosun Group" are far beyond our imagination！
Fosun plans to sell a number of assets in September, the business being sold in addition to liquor, gold mines, and even the core business ......
Full-Life Technologies announced that it has signed an agreement to acquire Focus-X Therapeutics to expand its radiopharmaceuticals pipeline. Focus-X’s proprietary radioligand therapy (RLT) delivers alpha or beta emitters to break down cancer cell DNA......
Pediatrix Therapeutics announced a collaboration agreement with Aclaris Therapeutics to acquire the development, production and commercialization rights to Aclaris’s JAK1/3 inhibitor ATI-1777 for all indications in Greater China.
Tenacia Biotechnology (Shanghai) Co., Ltd. is an emerging biotech headquartered in China, dedicated to the development of new drugs for central nervous system diseases. Tenacia recently introduced exclusive development and commercialization ......